Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5912 Journals
4984 Congresses
10800+ Unique Records

Antibody Therapeutics


Title Abbreviation
Antib Ther
Electronic ISSN
2516-4236
Readership
Biologists, Clinical Immunologists, Clinical Researchers, Clinicians, Cytologists/Cell Biologists, Immunohematologists, Immunologists, Molecular Biologists, Researchers, Scientists, Scientists - Research/Biomedical Aging
Scope
A peer-reviewed, online, open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community. Topics include target and antibody discovery, mechanistic research, new technologies and methods, manufacturing, clinical trials, regulation, policies, and more. Antibody Therapeutics article types include original research, reviews, cutting-edge technologies, new methods, news, interviews, and meeting highlights.
Sponsoring Association(s)
Chinese Antibody Society (ChAbS)
Publisher Name
Oxford University Press
To see more details about Antibody Therapeutics, Subscribe Now!
Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library